[1]
Kareemulla, S., Himabindu, B., Khan, D.S., Ramu, G. and Rafi, S.M. 2021. SAFETY AND TOLERABILITY OF VILDAGLIPTIN IN CLINICAL PRACTICE: NEWER PROMISING GLIPTIN FOR TYPE 2 DIABETES MELLITUS. International Journal of Pharmaceutical and Biological Science Archive. 9, 1 (Mar. 2021).